PIPELINE
RevolKa is developing therapeutic drug candidates for various diseases and new industrial proteins, taking advantage of the wide range of indications by aiProtein®.
We also provide contract services for antibody enhancement in Japan.
This contract service is provided through FUJIFILM Wako Pure Chemical Corporation, so for details, please see the website.
| As of January 31, 2025 | |||||
| Project | Modality | Area | Development Stage | Status | Partner |
| RK001 | Antibody | Therapeutics (Immunooncotherapy) |
Technology development |
Completed |  |
| RK002 | Antibody | Therapeutics (Oncology) |
Technology development |
Completed | |
| RK003 | Protein | Therapeutics (Rare Disease) |
Undisclosed | Completed |  |
| RK004 | Protein | Undisclosed | Undisclosed | Completed |  |
RK006 |
Protein |
Undisclosed | Undisclosed | Working | Undisclosed |
| RK007 | Protein | Undisclosed | Undisclosed | Completed |  |
| RK008 | Protein | Undisclosed | Undisclosed | Working | Undisclosed |
| RK009 | Protein | Vaccines (Infectious diseases) |
Research collaboration |
Working |  |
| RK010 | Protein | Undisclosed | Undisclosed | Working | Undisclosed |
| RK011 | Protein | Undisclosed | Undisclosed | Completed | |
| RK012 | Protein | Undisclosed | Undisclosed | Working | Undisclosed |
| RK013 | Protein | Undisclosed | Undisclosed | New | Undisclosed |
| RK014 | Protein | Undisclosed | Undisclosed | New | Undisclosed |
| RK015 | Protein | Undisclosed | Undisclosed | New | |
| RK016 | Protein | Undisclosed | Undisclosed | New | |